학술논문
Emergence of dalbavancin non-susceptible, vancomycin-intermediate Staphylococcus aureus (VISA) after treatment of MRSA central line-associated bloodstream infection with a dalbavancin- and vancomycin-containing regimen
Document Type
Article
Author
Source
In Clinical Microbiology and Infection April 2018 24(4):429-429
Subject
Language
ISSN
1198-743X